Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Baltimore Inner Harbor

Apr 05, 2027 8:00 AM - Apr 07, 2027 12:30 PM

401 W Pratt Street, Baltimore, MD 21201, USA

Global Pharmacovigilance and Risk Management Strategies Conference

Early Bird Rate Ends

DAYS

HOURS

MINUTES

SECONDS

Session 3: Navigate the GLP-1 Wave: PV Strategies for Consumer-Driven Use, Data, and Signals

Session Chair(s)

Vanessa  Zapata

Vanessa Zapata

Associate Director, Global Clinical Safety & Pharmacovigilance Training Lead , Merck & Co., Inc., Canada

Stephanie  Millican, PhD, MSc

Stephanie Millican, PhD, MSc

Deputy Director Benefit Risk Evaluation, Safety and Surveillance, MHRA, United Kingdom

GLP-1 therapies are reshaping pharmacovigilance as consumer demand, real-world use, digital discussion, and nontraditional access channels accelerate safety-data generation. This panel will examine how pharma safety and epidemiology/RWE teams can interpret signals across spontaneous reports, social media, patient communities, telehealth pathways, compounded or counterfeit products, and real-world evidence, while managing the operational challenges created by unprecedented reporting volumes. Speakers will discuss how regional regulatory expectations and available guidance may differ across markets, and share practical lessons for separating signal from noise, communicating risk, and applying the GLP-1 experience to future consumer-driven medicines.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify PV challenges created by consumer-driven GLP-1 use, reporting, and digital discussion
  • Differentiate signal from noise across spontaneous reports, RWE, social media, and patient-generated data
  • Apply practical considerations for risk communication and benefit-risk assessment in high-visibility GLP-1 settings

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.